CTI BioPharma Corp. (CTIC)
Jun 26, 2023 - CTIC was delisted (reason: acquired by Sobi)
9.09
0.00 (0.00%)
Last trade price
CTI BioPharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 53.95 | 0 | 0 | 3.35 | 26.29 | 25.15 | 57.41 | 16.12 | 60.08 | 34.68 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | -87.28% | 4.55% | -56.20% | 256.20% | -73.17% | 73.24% | - | Upgrade
|
| Cost of Revenue | 3.51 | 0 | 0 | 0 | 0 | 0.36 | 1.38 | 1.94 | 0.9 | 0.14 | Upgrade
|
| Gross Profit | 50.43 | 0 | 0 | 3.35 | 26.29 | 24.78 | 56.03 | 14.18 | 59.18 | 34.54 | Upgrade
|
| Selling, General & Admin | 84.83 | 56.2 | 17.63 | 19.16 | 22.06 | 31.44 | 45.31 | 53.96 | 56.24 | 42.44 | Upgrade
|
| Research & Development | 36.9 | 39.14 | 25.94 | 24.11 | 36.47 | 32.87 | 64.96 | 76.63 | 64.6 | 33.62 | Upgrade
|
| Other Operating Expenses | 8.51 | 0 | 4.2 | 0.79 | 0.66 | 0 | -5.08 | 0.25 | 24.58 | 0 | Upgrade
|
| Operating Expenses | 130.23 | 95.33 | 47.77 | 44.06 | 59.19 | 64.3 | 105.19 | 130.84 | 145.42 | 76.07 | Upgrade
|
| Operating Income | -79.8 | -95.33 | -47.77 | -40.71 | -32.9 | -39.52 | -49.16 | -116.67 | -86.23 | -41.53 | Upgrade
|
| Interest Expense / Income | 13.14 | 2.42 | 0.83 | 1 | 1.21 | 1.87 | 2.61 | 2.1 | 1.95 | 1.03 | Upgrade
|
| Other Expense / Income | 0.06 | 0.16 | 3.85 | -1.69 | -4.79 | -0.72 | 0.23 | 0.65 | 5.19 | 0.19 | Upgrade
|
| Pretax Income | -92.99 | -97.91 | -52.45 | -40.02 | -29.32 | -40.67 | -52.01 | -119.42 | -93.37 | -42.74 | Upgrade
|
| Net Income | -92.99 | -97.91 | -52.45 | -40.02 | -29.32 | -40.67 | -52.01 | -119.42 | -93.37 | -42.74 | Upgrade
|
| Preferred Dividends | 0 | 0 | 0 | 0 | 0.08 | 4.35 | 0 | 3.2 | 2.63 | 6.9 | Upgrade
|
| Net Income Common | -92.99 | -97.91 | -52.45 | -40.02 | -29.4 | -45.02 | -52.01 | -122.62 | -95.99 | -49.64 | Upgrade
|
| Shares Outstanding (Basic) | 115 | 90 | 71 | 58 | 56 | 36 | 28 | 19 | 15 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 115 | 90 | 71 | 58 | 56 | 36 | 28 | 19 | 15 | 11 | Upgrade
|
| Shares Change | 27.27% | 26.67% | 22.71% | 3.39% | 53.86% | 30.40% | 48.37% | 26.82% | 30.07% | 96.46% | Upgrade
|
| EPS (Basic) | -0.81 | -1.09 | -0.74 | -0.69 | -0.52 | -1.24 | -1.86 | -6.51 | -6.46 | -4.30 | Upgrade
|
| EPS (Diluted) | -0.81 | -1.09 | -0.74 | -0.69 | -0.52 | -1.24 | -1.86 | -6.51 | -6.46 | -4.30 | Upgrade
|
| Free Cash Flow | -81.19 | -84.89 | -42.22 | -27.82 | -39.86 | -39.35 | -76.82 | -95.28 | -39.88 | -37.36 | Upgrade
|
| Free Cash Flow Per Share | -0.71 | -0.94 | -0.59 | -0.48 | -0.71 | -1.08 | -2.75 | -5.06 | -2.69 | -3.27 | Upgrade
|
| Gross Margin | 93.49% | - | - | 100.00% | 100.00% | 98.55% | 97.60% | 87.96% | 98.51% | 99.60% | Upgrade
|
| Operating Margin | -147.91% | - | - | -1217.07% | -125.14% | -157.16% | -85.64% | -723.91% | -143.54% | -119.75% | Upgrade
|
| Profit Margin | -172.37% | - | - | -1196.41% | -111.83% | -179.03% | -90.60% | -760.87% | -159.78% | -143.15% | Upgrade
|
| Free Cash Flow Margin | -150.50% | - | - | -831.75% | -151.61% | -156.47% | -133.82% | -591.22% | -66.39% | -107.75% | Upgrade
|
| EBITDA | -77.9 | -94.97 | -51.09 | -38.47 | -27.52 | -38.08 | -48.56 | -116.33 | -90.32 | -40.15 | Upgrade
|
| EBITDA Margin | -144.40% | - | - | -1150.13% | -104.67% | -151.44% | -84.60% | -721.82% | -150.34% | -115.77% | Upgrade
|
| Depreciation & Amortization | 1.95 | 0.53 | 0.53 | 0.55 | 0.59 | 0.72 | 0.83 | 0.99 | 1.1 | 1.57 | Upgrade
|
| EBIT | -79.85 | -95.49 | -51.62 | -39.02 | -28.11 | -38.8 | -49.4 | -117.32 | -91.42 | -41.72 | Upgrade
|
| EBIT Margin | -148.02% | - | - | -1166.46% | -106.93% | -154.29% | -86.05% | -727.96% | -152.17% | -120.30% | Upgrade
|